152 related articles for article (PubMed ID: 8013262)
1. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?
Gregorio F; Cristallini S; Santeusanio F; Filipponi P; Fumelli P
Diabetes Res Clin Pract; 1994 Feb; 23(1):43-54. PubMed ID: 8013262
[TBL] [Abstract][Full Text] [Related]
2. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus.
Nagasaka S; Murakami T; Uchikawa T; Ishikawa SE; Saito T
Endocr J; 1995 Jun; 42(3):377-83. PubMed ID: 7670567
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
4. Increasing serum osteocalcin after glycemic control in diabetic men.
Sayinalp S; Gedik O; Koray Z
Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis.
McNair P; Madsbad S; Christensen MS; Christiansen C; Faber OK; Binder C; Transbøl I
Acta Endocrinol (Copenh); 1979 Mar; 90(3):463-72. PubMed ID: 425786
[TBL] [Abstract][Full Text] [Related]
6. Lumbar spine bone mineral density in diabetic children with recent onset.
De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
[TBL] [Abstract][Full Text] [Related]
7. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications.
Mathiassen B; Nielsen S; Johansen JS; Hartwell D; Ditzel J; Rødbro P; Christiansen C
J Diabet Complications; 1990; 4(4):145-9. PubMed ID: 2151224
[TBL] [Abstract][Full Text] [Related]
8. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
9. Reduced serum osteocalcin and 1,25-dihydroxyvitamin D concentrations and low bone mineral content in small for gestational age infants: evidence of decreased bone formation rates.
Namgung R; Tsang RC; Specker BL; Sierra RI; Ho ML
J Pediatr; 1993 Feb; 122(2):269-75. PubMed ID: 8429446
[TBL] [Abstract][Full Text] [Related]
10. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
11. Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients.
Suzuki K; Sugimoto C; Takizawa M; Ishizuka S; Kikuyama M; Togawa H; Taguchi Y; Nosaka K; Seino Y; Ishida H
Diabetes Res Clin Pract; 2000 Jun; 48(3):185-91. PubMed ID: 10802157
[TBL] [Abstract][Full Text] [Related]
12. Fractional calcium absorption is increased in girls with Rett syndrome.
Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
[TBL] [Abstract][Full Text] [Related]
13. Relative weight of glucose, insulin and parathyroid hormone in the urinary loss of phosphate by chronically diabetic rats.
Locatto ME; Di Loreto V; Fernández MC; Caferra D; Puche RC
Acta Diabetol; 1997 Oct; 34(3):211-6. PubMed ID: 9401643
[TBL] [Abstract][Full Text] [Related]
14. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
15. Osteocalcin levels in diabetic subjects.
Pedrazzoni M; Ciotti G; Pioli G; Girasole G; Davoli L; Palummeri E; Passeri M
Calcif Tissue Int; 1989 Dec; 45(6):331-6. PubMed ID: 2804765
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus.
Auwerx J; Dequeker J; Bouillon R; Geusens P; Nijs J
Diabetes; 1988 Jan; 37(1):8-12. PubMed ID: 3335279
[TBL] [Abstract][Full Text] [Related]
18. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
[TBL] [Abstract][Full Text] [Related]
19. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
[TBL] [Abstract][Full Text] [Related]
20. Effects of insulin on altered mineral and vitamin D metabolism in streptozotocin-induced diabetes.
Ishida H; Seino Y; Nishi S; Kitano N; Seno M; Taminato T; Matsukura S; Ishizuka S; Imura H
Acta Endocrinol (Copenh); 1985 Feb; 108(2):231-6. PubMed ID: 3881888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
